Covestor Ltd Has $32,000 Holdings in Embecta Corp. (NASDAQ:EMBC)

Covestor Ltd reduced its holdings in Embecta Corp. (NASDAQ:EMBC) by 24.1% during the 3rd quarter, Holdings Channel reports. The fund owned 2,263 shares of the company’s stock after selling 717 shares during the quarter. Covestor Ltd’s holdings in Embecta were worth $32,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also modified their holdings of EMBC. Commerzbank Aktiengesellschaft FI acquired a new position in Embecta during the 3rd quarter worth $470,000. Copeland Capital Management LLC acquired a new position in Embecta during the 3rd quarter worth $43,000. Inspire Advisors LLC lifted its holdings in Embecta by 108.3% during the 3rd quarter. Inspire Advisors LLC now owns 31,169 shares of the company’s stock worth $439,000 after buying an additional 16,207 shares in the last quarter. Inspire Investing LLC acquired a new position in Embecta during the 3rd quarter worth $413,000. Finally, CWM LLC lifted its holdings in Embecta by 11.3% during the 3rd quarter. CWM LLC now owns 10,102 shares of the company’s stock worth $142,000 after buying an additional 1,023 shares in the last quarter. 93.83% of the stock is owned by institutional investors and hedge funds.

Embecta Stock Performance

NASDAQ:EMBC opened at $14.62 on Friday. The stock’s fifty day moving average price is $14.55 and its two-hundred day moving average price is $13.86. The company has a market cap of $843.60 million, a price-to-earnings ratio of 12.18 and a beta of 0.97. Embecta Corp. has a 52-week low of $9.93 and a 52-week high of $19.79.

Embecta Profile

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes.